News They are still moving forward. Very quiet company just implementing a businee plan and not all hype.
"Calgary, Alberta – TheNewswire - March 22 nd , 2021 – Voyageur Pharmaceuticals Ltd. ( TSX.V : VM ) USA (OTC : VYYRF) (the "Company" or "Voyageur") announces that it has signed a cost plus manufacturing agreement with Alberta Veterinarian Laboratories Ltd. ("AVL"). This agreement allows Voyageur to begin the process of formulating and testing our new products with AVL and prepare for production and sales. AVL is committing mixing and fill lines for Voyageur's production. Voyageur and AVL are working jointly to create high quality health products for the clinical radiology market. AVL will be responsible for all Active Pharmaceutical Ingredients ("API") formulation, bottling and packaging. Voyageur will focus on country by country regulatory approvals, marketing, sales, logistics, distribution and supply-chain management to enter the North American market and new markets worldwide.
Voyageur will be finalizing the product lines and implementing final testing of products prior to full production start up. The pre-production phase is estimated to be completed in Q4 2021 and entails packaging design, fill line design & testing, laboratory batch testing, client batch testing, forward sales and marketing.
AVL recently completed construction in January 2021, of its modern and state of the art Good Manufacturing Practice ("GMP") pharmaceutical manufacturing facility. AVL received its Drug Establishment Licence (DEL) and have passed the inspection and are in full compliance for manufacturing, testing, distribution, importing API and labelling of powders, solutions, suspensions, pastes, ointments. Voyageur is excited to work with AVL and to continue to move Voyageur towards cash flow and full integration of its barium radiographic product lines and barium quarry."